Affiliation:
1. College of Pharmacy, The University of Iowa, Iowa City, Iowa 52242
2. College of Pharmacy, Ferris State University, Big Rapids, Michigan 49307
3. Borgess Medical Center Department of Pharmacy, Kalamazoo, Michigan 49001
Abstract
ABSTRACT
We evaluated the in vitro activity of the new echinocandin antifungal micafungin against
Candida
spp. using microdilution and time-kill methods. Additionally, we examined the postantifungal effect (PAFE) of micafungin. Finally, we evaluated the effect of the addition of serum and plasma on the MIC of micafungin. Four
Candida albicans
isolates and two isolates of each
Candida glabrata
,
Candida krusei
, and
Candida tropicalis
were selected for testing. The MICs of micafungin were determined in RPMI 1640 medium buffered with morpholinepropanesulfonic acid alone and with the addition of 10, 20, and 50% human serum and plasma. MICs were determined by using two endpoints: a prominent reduction in growth (the MIC at which 80% of isolates are inhibited [MIC
80
]) and complete visual inhibition of growth (MIC
100
). The minimum fungicidal concentration (MFC) of micafungin for each isolate was also determined. Time-kill curves were determined for each isolate in RPMI 1640 medium with micafungin at concentrations ranging from 0.125 to 16 times the MIC
80
to assess the correlation between MIC
80
and fungicidal activity. PAFE studies were conducted with each isolate by using concentrations ranging between 0.25 and 4 times the MIC
80
. The MIC
80
s for the test isolates ranged from 0.0039 to 0.25 μg/ml. Overall, the addition of serum or plasma increased the MIC 6 to 7 doubling dilutions for
C. albicans
and 3 to 4 doubling dilutions for
C. krusei
and
C. tropicalis
. Micafungin time-kill studies demonstrated fungicidal activity at concentrations ranging from 4 to 16 times the MIC
80
. Micafungin is very potent agent against a variety of
Candida
spp., producing fungicidal activity against 7 of 10 isolates tested. A PAFE was observed against all isolates. The PAFE was influenced by the drug concentration, with the highest concentration resulting in the longest observed PAFE in each case. The highest concentration tested, four times the MIC, resulted in a PAFE of more than 9.8 h for 5 of 10 isolates tested (range, 0.9 to ≥20.1 h).
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Cited by
141 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献